Skip to content

Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

Clinical Study of Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00844584
Enrollment
20
Registered
2009-02-16
Start date
2008-10-31
Completion date
2011-06-30
Last updated
2009-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial fibrillation, radiofrequency, totally thoracoscope, epicardial

Brief summary

Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The fact that pharmacological therapy of AF is at best 50% effective has led to a search for surgical approaches over the last 20 years. Maze procedure was a classic method to treat AF. However, it is such a complex procedure that very few surgeons have adopted it. A few minimally invasive procedures to create transmural lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is catheter-based radiofrequency ablation, another one is video assisted epicardial radiofrequency ablation through small thoracic incisions in operating room. Recently, we invented an epicardial radiofrequency ablation method under totally thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.

Interventions

PROCEDUREepicardial radiofrequency ablation

epicardial radiofrequency ablation to treat atrial fibrillation under totally thoracoscope

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Any patients with atrial fibrillation

Exclusion criteria

* Patients with hemostasis defects * patients can not endure general anesthesia

Design outcomes

Primary

MeasureTime frame
Electrocardiography2 years

Countries

China

Contacts

Primary ContactZhenxiao Jin, MD
jinzx10262@yahoo.com.cn86-29-84771022
Backup ContactDinghua Yi, MD
yidinghua@yahoo.com.cn86-29-84775307

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026